BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17264178)

  • 1. Short-term manipulation of plasma free fatty acids does not change skeletal muscle concentrations of ceramide and glucosylceramide in lean and overweight subjects.
    Serlie MJ; Meijer AJ; Groener JE; Duran M; Endert E; Fliers E; Aerts JM; Sauerwein HP
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1524-9. PubMed ID: 17264178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a sustained reduction in plasma free fatty acid concentration on insulin signalling and inflammation in skeletal muscle from human subjects.
    Liang H; Tantiwong P; Sriwijitkamol A; Shanmugasundaram K; Mohan S; Espinoza S; Defronzo RA; Dubé JJ; Musi N
    J Physiol; 2013 Jun; 591(11):2897-909. PubMed ID: 23529132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal muscle lipogenic protein expression is not different between lean and obese individuals: a potential factor in ceramide accumulation.
    Thrush AB; Brindley DN; Chabowski A; Heigenhauser GJ; Dyck DJ
    J Clin Endocrinol Metab; 2009 Dec; 94(12):5053-61. PubMed ID: 19837942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceramide content is increased in skeletal muscle from obese insulin-resistant humans.
    Adams JM; Pratipanawatr T; Berria R; Wang E; DeFronzo RA; Sullards MC; Mandarino LJ
    Diabetes; 2004 Jan; 53(1):25-31. PubMed ID: 14693694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced circadian ACTH release in obese premenopausal women: reversal by short-term acipimox treatment.
    Kok P; Kok SW; Buijs MM; Westenberg JJ; Roelfsema F; Frölich M; Stokkel MP; Meinders AE; Pijl H
    Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E848-56. PubMed ID: 15280154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
    Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
    Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceramide content is higher in type I compared to type II fibers in obesity and type 2 diabetes mellitus.
    Kristensen D; Prats C; Larsen S; Ara I; Dela F; Helge JW
    Acta Diabetol; 2013 Oct; 50(5):705-12. PubMed ID: 22350135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of growth hormone (GH) response to GH-releasing hormone in elderly and obese subjects by acute pharmacological reduction of plasma free fatty acids.
    Pontiroli AE; Manzoni MF; Malighetti ME; Lanzi R
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3998-4001. PubMed ID: 8923850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endurance training modulates intramyocellular lipid compartmentalization and morphology in skeletal muscle of lean and obese women.
    Devries MC; Samjoo IA; Hamadeh MJ; McCready C; Raha S; Watt MJ; Steinberg GR; Tarnopolsky MA
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4852-62. PubMed ID: 24081737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic treatment with pioglitazone does not protect obese patients with diabetes mellitus type II from free fatty acid-induced insulin resistance.
    Serlie MJ; Allick G; Groener JE; Ackermans MT; Heijligenberg R; Voermans BC; Aerts JM; Meijer AJ; Sauerwein HP
    J Clin Endocrinol Metab; 2007 Jan; 92(1):166-71. PubMed ID: 17062758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of an increased free fatty acid concentration on thermogenesis and substrate oxidation in obese and lean men.
    Schiffelers SL; Saris WH; van Baak MA
    Int J Obes Relat Metab Disord; 2001 Jan; 25(1):33-8. PubMed ID: 11244455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic and endocrine consequences of acute suppression of FFAs by acipimox in polycystic ovary syndrome.
    Ciampelli M; Muzj G; Leoni F; Romualdi D; Belosi C; Cento RM; Lanzone A
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5324-9. PubMed ID: 11701699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin.
    Dandona P; Aljada A; Ghanim H; Mohanty P; Tripathy C; Hofmeyer D; Chaudhuri A
    J Clin Endocrinol Metab; 2004 Oct; 89(10):5043-7. PubMed ID: 15472203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle adaptation to short-term fasting in healthy lean humans.
    Soeters MR; Sauerwein HP; Dubbelhuis PF; Groener JE; Ackermans MT; Fliers E; Aerts JM; Serlie MJ
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2900-3. PubMed ID: 18397976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular glucose metabolism after long term metabolic control with glyburide: improved glucose oxidation with unchanged glycogen synthase activity.
    Suh KI; Murata C; Song YM; Joyce M; Gumbiner B; Ditzler TM; Henry RR
    J Clin Endocrinol Metab; 1993 Aug; 77(2):464-70. PubMed ID: 8345053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of fasting on insulin action and glucose kinetics in lean and obese men and women.
    Bergman BC; Cornier MA; Horton TJ; Bessesen DH
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1103-11. PubMed ID: 17684102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long- and medium-chain fatty acids induce insulin resistance to a similar extent in humans despite marked differences in muscle fat accumulation.
    Hoeks J; Mensink M; Hesselink MK; Ekroos K; Schrauwen P
    J Clin Endocrinol Metab; 2012 Jan; 97(1):208-16. PubMed ID: 22031508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal patterns of circulating leptin levels in lean and obese adolescents: relationships to insulin, growth hormone, and free fatty acids rhythmicity.
    Heptulla R; Smitten A; Teague B; Tamborlane WV; Ma YZ; Caprio S
    J Clin Endocrinol Metab; 2001 Jan; 86(1):90-6. PubMed ID: 11231983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of hexosamines in insulin resistance and nutrient sensing in human adipose and muscle tissue.
    Pouwels MJ; Tack CJ; Span PN; Olthaar AJ; Sweep CG; Huvers FC; Lutterman JA; Hermus AR
    J Clin Endocrinol Metab; 2004 Oct; 89(10):5132-7. PubMed ID: 15472217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of obesity on substrate utilization during exercise.
    Goodpaster BH; Wolfe RR; Kelley DE
    Obes Res; 2002 Jul; 10(7):575-84. PubMed ID: 12105277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.